SURG, Synergetics USA, Inc.

** SURG reported that for the fourth quarter fiscal 2011, its net income rose 100% to $2.0 million and its sales rose 21% to a record $15.8 million compared to the same period in the prior year.

SURG is a leading supplier of precision surgical devices. SURG's primary focus is on the disciplines of ophthalmology and neurosurgery.

Medicis Pharmaceutical Corp. (NYSE:MRX) engages in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States, Canada, and Europe. Medicis Pharmaceutical is dedicated to helping patients attain a healthy and youthful appearance and self-image.

Tufco Technologies Inc. (Nasdaq:TFCO) announced the appointment of Tony Aitkin as Plant Operations Manager of its Green Bay, Wisconsin Contract Manufacturing Division. Tony joins Tufco with broad experience in engineering, maintenance, quality and operational management in paper and tissue converting, corrugated containerboard, aerospace and medical device industries.